These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8862984)

  • 21. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
    Stessin AM; Meyer JE; Sherr DL
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance of US deaths related to myelodysplastic syndromes, and the need for linkages with central cancer registries.
    Polednak AP
    J Registry Manag; 2011; 38(4):183-9. PubMed ID: 23270091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemiology of colorectal cancer: what can we learn from the New Zealand Cancer Registry?
    Keating J; Pater P; Lolohea S; Wickremesekera K
    N Z Med J; 2003 May; 116(1174):U437. PubMed ID: 12766783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability of causes of death in persons with Type I diabetes.
    Mühlhauser I; Sawicki PT; Blank M; Overmann H; Richter B; Berger M
    Diabetologia; 2002 Nov; 45(11):1490-7. PubMed ID: 12436331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data.
    Hock LM; Lynch J; Balaji KC
    J Urol; 2002 Jan; 167(1):57-60. PubMed ID: 11743275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding bladder cancer death: tumor biology versus physician practice.
    Morris DS; Weizer AZ; Ye Z; Dunn RL; Montie JE; Hollenbeck BK
    Cancer; 2009 Mar; 115(5):1011-20. PubMed ID: 19152434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between diagnoses on death certificates and autopsy reports in Trieste: gynaecological cancers.
    Di Bonito L; Stanta G; Delendi M; Peruzzo P; Gardiman D; Cocchi A; Patriarca S; Giarelli L
    IARC Sci Publ; 1991; (112):63-71. PubMed ID: 1855951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. End-of-life decisions among cancer patients compared with noncancer patients in Flanders, Belgium.
    Van den Block L; Bilsen J; Deschepper R; Van der Kelen G; Bernheim JL; Deliens L
    J Clin Oncol; 2006 Jun; 24(18):2842-8. PubMed ID: 16782923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.
    Konety BR; Joslyn SA; O'Donnell MA
    J Urol; 2003 Mar; 169(3):946-50. PubMed ID: 12576819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deaths: final data for 1997.
    Hoyert DL; Kochanek KD; Murphy SL
    Natl Vital Stat Rep; 1999 Jun; 47(19):1-104. PubMed ID: 10410536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants and interpretation of death certificate only proportions in the initial years of newly established cancer registries.
    Brenner H; Jansen L
    Eur J Cancer; 2013 Mar; 49(4):931-7. PubMed ID: 23084081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using birth defects registry data to evaluate infant and childhood mortality associated with birth defects: an alternative to traditional mortality assessment using underlying cause of death statistics.
    Copeland GE; Kirby RS
    Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):792-7. PubMed ID: 17990340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995.
    Albertsen PC; Walters S; Hanley JA
    J Urol; 2000 Feb; 163(2):519-23. PubMed ID: 10647669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uterine cancers of unspecified origin--a reassessment.
    Percy CL; Horm JW; Young JL; Asire AJ
    Public Health Rep; 1983; 98(2):176-80. PubMed ID: 6856742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease as a cause of death in the United States.
    Hoyert DL; Rosenberg HM
    Public Health Rep; 1997; 112(6):497-505. PubMed ID: 10822478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inaccuracies in oral cavity-pharynx cancer coded as the underlying cause of death on U.S. death certificates, and trends in mortality rates (1999-2010).
    Polednak AP
    Oral Oncol; 2014 Aug; 50(8):732-9. PubMed ID: 24862544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary system.
    Lynch CF; Cohen MB
    Cancer; 1995 Jan; 75(1 Suppl):316-29. PubMed ID: 8001003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.